Man Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.93M Buy
414,484
+325,710
+367% +$3.33M 0.01% 1165
2025
Q4
$884K Buy
88,774
+17,371
+24% +$166K ﹤0.01% 1714
2025
Q3
$639K Buy
+71,403
New +$661K ﹤0.01% 1793
2025
Q2
Sell
-31,646
Closed -$343K 2156
2025
Q1
$343K Buy
+31,646
New +$318K ﹤0.01% 1901
2024
Q4
Sell
-10,137
Closed -$114K 1972
2024
Q3
$114K Buy
+10,137
New +$108K ﹤0.01% 1892
2023
Q3
Hold
0
1843
2023
Q1
Hold
0
1164
2022
Q2
Hold
0
1446
2022
Q1
Sell
-8,211
Closed -$201K 2168
2021
Q4
$201K Sell
8,211
-18,389
-69% -$432K ﹤0.01% 1803
2021
Q3
$620K Buy
26,600
+12,900
+94% +$312K ﹤0.01% 1482
2021
Q2
$376K Sell
13,700
-49,055
-78% -$1.4M ﹤0.01% 1632
2021
Q1
$2.31M Buy
+62,755
New +$2.22M 0.01% 1052

Other funds holding AHCO

Man Group's AHCO Position: Q1 2026 in Review

Man Group increased its AdaptHealth (AHCO) stake by 367% in Q1 2026, buying an estimated $3.33M and bringing the position to 414,484 shares worth $4.93M. The position accounts for 0.01% of the portfolio, ranked #1165.

Man Group first reported a position in AHCO in Q1 2021 and has held it in 9 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Man Group held 414,484 shares of AdaptHealth worth $4.93M as of Q1 2026.
  • Man Group bought 325,710 AdaptHealth shares in Q1 2026, an estimated $3.33M.
  • AdaptHealth made up 0.01% of Man Group's portfolio in Q1 2026, its #1165 holding.
  • Man Group first reported a position in AdaptHealth in Q1 2021 and has held it in 9 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.